Description

Twinrix is a bivalent vaccine containing the antigenic components used in producing HAVRIX (strain HM175) and ENGERIX-B [noninfectious hepatitis B virus surface antigen (HBsAg).].

Indication

Twinrix is indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. 

Dosage

Twinrix is a sterile suspension for intramuscular administration.

Twinrix is approved for use in persons 18 years of age or older.